Tectonic Therapeutic (TECX) Equity Average (2018 - 2026)

Tectonic Therapeutic (TECX) has 9 years of Equity Average data on file, last reported at $240.9 million in Q1 2026.

• Equity Average for Q1 2026 came in at $240.9 million, up 9.04% year-over-year; the trailing twelve-month figure through Mar 2026 was $240.9 million (up 9.04% YoY), and the FY2025 annual result was $196.1 million, up 598.44% from the prior year.
• Equity Average fell to $240.9 million in Q1 2026 per TECX's latest filing, from $259.4 million in the prior quarter.
• Over five years, Equity Average peaked at $292.4 million in Q2 2025 and troughed at -$92.1 million in Q1 2024.
• A 5-year average of $98.9 million and a median of $130.8 million in 2022 frame the typical range for Equity Average.
• The sharpest annual moves came in 2023 and 2025: Equity Average sank 413.56% in 2023, then soared 775.54% in 2025.
• A 5-year view of Equity Average shows it stood at $26.2 million in 2022, then slumped by 413.56% to -$82.2 million in 2023, then jumped by 277.07% to $145.6 million in 2024, then surged by 78.22% to $259.4 million in 2025, then retreated by 7.15% to $240.9 million in 2026.
• Business Quant data shows TECX's Equity Average at $240.9 million in Q1 2026, $259.4 million in Q4 2025, and $275.6 million in Q3 2025.